Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03038763 · ClinicalTrials.gov registry record
Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 100
- Enrollment target
NCT03038763: Completed study, sponsored by University of Pennsylvania.
NCT03038763 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03038763 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators aim to determine the prevalence of hepatitis C in the adult children of female baby boomers. During the years baby boomers were becoming pregnant, hepatitis C testing was either not available or was not standard of care. Because of this, participants' children may be unaware of participants' risk of hepatitis C.
Primary Outcome
Prevalence of HCV in adult children of female baby boomers who have or have had HCV
Interventions
- OTHER Eligibility Screening
- DIAGNOSTIC_TEST HCV test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-11 |
| Est. Completion | 2019-06-30 |
What the finished NCT03038763 record still lists
NCT03038763 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Eligibility Screening is the first listed.
NCT03038763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03038763 about?
NCT03038763 is a clinical study titled "Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers". The investigators aim to determine the prevalence of hepatitis C in the adult children of female baby boomers. During the years baby boomers were becoming pregnant, hepatitis C testing was either not available or was not standard of care. Because of this, participants' children may be unaware of par...
What is the current status of trial NCT03038763?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-05-11. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03038763?
The interventions under investigation include: Eligibility Screening (OTHER), HCV test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03038763?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI